Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?

Elif Hindié, Paolo Zanotti-Fregonara, Françoise Duron, Isabelle Keller, Philippe Bouchard, Jean Yves Devaux

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?'. Together they form a unique fingerprint.

Medicine & Life Sciences